Phio Pharmaceuticals Corp. (PHIO) — 10-Q Filings
All 10-Q filings from Phio Pharmaceuticals Corp.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Phio Pharma's Losses Widen Amid Increased R&D, Cash Position Improves
— Nov 13, 2025 Risk: high
Phio Pharmaceuticals Corp. reported a net loss of $2.392 million for the three months ended September 30, 2025, an increase from a net loss of $1.524 million in -
Phio Pharma's Losses Widen Amid Increased R&D, Cash Boosted by Financing
— Aug 14, 2025 Risk: high
Phio Pharmaceuticals Corp. reported a net loss of $2.166 million for the three months ended June 30, 2025, compared to a net loss of $1.846 million for the same -
Phio Pharmaceuticals Files Q1 2025 10-Q
— May 15, 2025 Risk: medium
Phio Pharmaceuticals Corp. filed its quarterly report for the period ending March 31, 2025. The company, formerly RXi Pharmaceuticals Corp., is based in Marlbor -
Phio Pharmaceuticals Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Phio Pharmaceuticals Corp. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and operational highlights. Key f -
Phio Pharmaceuticals Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Phio Pharmaceuticals Corp. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first six m -
Phio Pharmaceuticals Corp. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
Phio Pharmaceuticals Corp. (PHIO) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Phio Pharmaceuticals Corp. reported its Q1 2024 results on May 9,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX